NXI Therapeutics AG

Novel Therapy for Autoimmunity and Organ Transplantation.

Swiss Startup - NXI Therapeutics Main Image

NXI Therapeutics intends to commence operations with screening and preclinical development of compounds that interfere with coronin 1-dependent T cell activation in autoimmune diseases and organ transplantation. A biomarker and a diagnostic program targeted towards the development of assay systems to analyse the effectiveness of the therapy and naïve T cell populations for use in patients undergoing immunosuppression is optional.

Only registered users have access to funding information.
Please log in or register to continue. Registration is free.

16.06.2025

Access to global accelerators for three MedTech start-ups (startupticker.ch)

06.09.2024

Kickfund invests at full throttle (startupticker.ch)

19.06.2024

NXI Therapeutics extends pre-seed financing to CHF 3.5 million (startupticker.ch)

06.11.2023

A decent representation at BIO-Europe (startupticker.ch)

16.12.2022

The 18 most promising biotech startups, according to investors (TOP 100)

28.09.2022

Israeli-Swiss Lean Launchpad Program 2022 supports eight startups (startupticker.ch)

01.09.2022

Ten startups to explore India (startupticker.ch)

27.06.2022

NextImmune wins CHF 150,000 to develop a new generation of immunosuppressive drugs (startupticker.ch)

27.06.2022

NextImmune wins CHF 150,000 to develop a new generation of immunosuppressive drugs for autoimmune diseases and organ transplantation (venturekick.ch)

12.05.2022

InnoBooster projects have high ambitions (startupticker.ch)

17.11.2021

The Venture Leaders Biotech dive into the Boston ecosystem (venturelab.swiss)

30.09.2021

Sino-Swiss Pitchinar: Selected Swiss biotech startups pitch to Chinese investors and enterprises (venturelab.swiss)

24.09.2021

Meet NextImmune co-founder Rajesh Jayachandran and find out how he advances the development of novel immunosuppressants (venturelab.swiss)

13.09.2021

The Venture Leaders Biotech 2021 kick off their international roadshow at the Swiss Biotech Day (venturelab.swiss)

14.07.2021

Venture Leaders Biotech 2021: 10 new Swiss National Startup Team members to showcase Swiss biotech innovation on the global stage (venturelab.swiss)

No milestones

No Jobs

No videos and documents

TOP 100 Swiss Startup Award

The TOP 100 Swiss Startup Ranking features the 100 most promising startups that are not older than five years and are selected by a jury of early-stage investors.

TOP 100 Swiss Startups 2025 TOP 100 Swiss Startups 2022

Website

Venture Kick

Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.

Venture Kick (150'000) 2022

Website